Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiashu Han

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Cancer Cell International|October 11, 2025
EDC4 enhances multi-drug chemosensitivity in pancreatic cancer via GR50-based profilingCheng Qin, Tianyu Li, Bangbo Zhao, et al.
Frontiers in Medicine|April 20, 2026
Case Report: IgG4-related autoimmune pancreatitis presenting as an infiltrative cystic-solid pancreatic mass: lessons from a diagnostic pitfallRan Xiao, Tianyu Li, Bo Chen, et al.
Molecular Cancer|August 30, 2022
S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancerHongnan Mo, Xuefeng Liu, Yu Xue, et al.
Journal of Cancer|May 6, 2024
Neoadjuvant targeted immunotherapy followed by surgical resection versus upfront surgery for hepatocellular carcinoma with macrovascular invasion: A multicenter studyXiang'an Wu, Yuxin Wang, Sen Wang, et al.
Molecular Cancer|December 28, 2024
THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancerXing Zhou, Jiashu Han, Anning Zuo, et al.
Molecular Cancer|June 26, 2025
Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancerXing Zhou, Jiashu Han, Anning Zuo, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cancer Cell International|October 11, 2025
EDC4 enhances multi-drug chemosensitivity in pancreatic cancer via GR50-based profilingCheng Qin, Tianyu Li, Bangbo Zhao, et al.
Frontiers in Medicine|April 20, 2026
Case Report: IgG4-related autoimmune pancreatitis presenting as an infiltrative cystic-solid pancreatic mass: lessons from a diagnostic pitfallRan Xiao, Tianyu Li, Bo Chen, et al.
Molecular Cancer|August 30, 2022
S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancerHongnan Mo, Xuefeng Liu, Yu Xue, et al.
Journal of Cancer|May 6, 2024
Neoadjuvant targeted immunotherapy followed by surgical resection versus upfront surgery for hepatocellular carcinoma with macrovascular invasion: A multicenter studyXiang'an Wu, Yuxin Wang, Sen Wang, et al.
Molecular Cancer|December 28, 2024
THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancerXing Zhou, Jiashu Han, Anning Zuo, et al.
Molecular Cancer|June 26, 2025
Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancerXing Zhou, Jiashu Han, Anning Zuo, et al.
Pageof 4